Companies: 10,795·Total market cap: $144.5T
PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLIOTCConsumer Defensive
$0.00
+$0.00(+9900.00%)
Market Cap$438307
P/E Ratio
52W High$0.0001
52W Low$0.000001

PacificHealth Laboratories, Inc.(PHLI)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PHLI · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2011-122010-122009-122008-122007-12
Revenue
Revenue$6.91M$7.20M$8.00M$7.24M$7.43M
Cost of Revenue$3.93M$4.04M$4.77M$4.21M$4.89M
Gross Profit$2.99M$3.16M$3.22M$3.02M$2.54M
Gross Margin %(computed)43.20%43.93%40.29%41.80%34.23%
Operating Expenses
R&D Expenses$0.05M$0.00M$0.00M$0.15M$0.21M
G&A Expenses$2.16M$2.75M$3.20M$3.54M$0.00M
Total Operating Expenses$3.46M$3.92M$5.08M$4.59M$3.90M
Operating Income($0.47M)($0.76M)($1.94M)($2.04M)($1.36M)
Operating Margin %(computed)-6.86%-10.56%-24.27%-28.19%-18.32%
Interest Income$0.00M$0.00M$0.00M$0.05M$0.07M
Interest Expense$0.01M$0.01M$0.01M$0.00M$0.00M
Income Before Tax($0.49M)($0.76M)($1.94M)($1.99M)($1.28M)
Income Tax Expense$0.00M$0.01M($0.26M)$0.00M$0.00M
Net Income($0.49M)($0.76M)($1.68M)($1.99M)($1.28M)
Net Margin %(computed)-7.03%-10.57%-20.96%-27.56%-17.18%
Per Share & EBITDA
EPS (Basic)$-0.02$-0.05$-0.11$-0.15$-0.10
Wtd Avg Shares19.55M16.15M14.97M13.66M13.31M
EBITDA($0.43M)($0.66M)($1.73M)($1.83M)($1.26M)
EBITDA Margin %(computed)-6.22%-9.11%-21.70%-25.33%-17.02%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解PacificHealth Laboratories, Inc.

关于PacificHealth Laboratories, Inc.(PHLI)损益表

PacificHealth Laboratories, Inc.(PHLI)损益表数据来源于SEC Form 10-K及10-Q申报文件。2011财年,PHLI实现营收$0.01B,毛利润$0.00B(毛利率43.20%),净利润($0.00B)(净利率-7.03%)。

常见问题

PHLI · 4 问

PacificHealth Laboratories, Inc.(PHLI)2011财年营收为$0.01B,同比down4.0%。

PHLI revenuePHLI salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08